This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Jul 9;378(9786):106-8.

doi: 10.1016/S0140-6736(11)60819-2. Epub 2011 Jun 24.

The case for diabetes screening: ADDITION-Europe

David Preiss¹, Naveed Sattar

Affiliations

PMID: 21705070
DOI: 10.1016/S0140-6736(11)60819-2

Comment

The case for diabetes screening: ADDITION-Europe

David Preiss et al. Lancet. 2011.

. 2011 Jul 9;378(9786):106-8.

doi: 10.1016/S0140-6736(11)60819-2. Epub 2011 Jun 24.

Authors

David Preiss¹, Naveed Sattar

Affiliation

¹ British Heart Foundation, Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

PMID: 21705070
DOI: 10.1016/S0140-6736(11)60819-2

No abstract available

PubMed Disclaimer

Comment on

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbæk A, Sharp SJ, Simmons RK, van den Donk M, Wareham NJ, Lauritzen T. Griffin SJ, et al. Lancet. 2011 Jul 9;378(9786):156-67. doi: 10.1016/S0140-6736(11)60698-3. Epub 2011 Jun 24. Lancet. 2011. PMID: 21705063 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information